Emerging immunotherapies for kidney cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Thomas Powles, MBBS, MRCP, MD, from Barts Cancer Institute, Queen Mary University of London, London, UK, provides an overview of promising novel immunotherapeutic strategies that are currently under investigation for the treatment of patients with kidney cancer.
Share this video  
Similar topics